From the Bench to the Bedside and Back: Contemporary Applications of Basic Science to Innovations in Heart Transplantation.

Heart transplantation remains the gold standard treatment for end-stage heart failure. Yet, challenges such as ischemia-reperfusion injury, primary graft dysfunction, allograft rejection, and cardiac allograft vasculopathy continue to affect long-term patient outcomes. In this contemporary review, we explore the applications of basic science in enhancing heart transplantation practices. We describe the molecular mechanisms of ischemic-reperfusion injuty, emphasizing the role of reactive oxygen species and mitochondrial dysfunction, which contribute to graft viability and post-transplant dysfunction. We also examine the evolution of preservation strategies, highlighting advancements from static cold storage to dynamic machine perfusion techniques, including hypothermic and normothermic systems that provide metabolic support and improve graft function. The potential of emerging biomarkers, such as circulating cell-free DNA and innovative diagnostic tools like the Molecular Microscope Diagnostic System, are discussed as vital tools for monitoring graft health and predicting rejection. By leveraging these advancements, the field of heart transplantation can address current challenges, improve patient outcomes, and enhance quality of life for transplant recipients. The importance of continued collaboration between researchers and clinicians in translating scientific discoveries into effective clinical applications cannot be overstated.